Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Phosphorus containing other than solely as part of an...
Patent
1994-12-20
1996-03-19
Daus, Donald G.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Phosphorus containing other than solely as part of an...
A61K 31675
Patent
active
055004199
ABSTRACT:
The present invention is directed to a new neuroprotective agent. The agent is R-4-oxo-5-phosphononorvaline. This agent is useful in the treatment of ischemic and hypoxic conditions such as stroke.
REFERENCES:
patent: 5326756 (1994-07-01), Whitten et al.
Kehne et al. Euro. J. of Pharmacol., vol. 193 pp. 283-292 (1991).
Kehne et al. Chem Abstr. vol. 114 Entry 199543e (1991).
Whitten et al. J. Med Chem. vol. 33 pp. 2963-2970 (1990).
Baron Bruce M.
Whitten Jeffrey P.
Daus Donald G.
Dixon J. Michael
Merrell Dow Pharmaceuticals Inc.
LandOfFree
NMDA antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with NMDA antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and NMDA antagonists will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1959444